| AMYLIN PHARMACEUTIC (NASDAQ:AMLN) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $12.77 | 52 Week High | $15.69 | ||
| Open | $12.74 | 52 Week Low | $5.50 | ||
| Day High | $12.77 | P/E | N/A | ||
| Day Low | $12.42 | EPS | $-1.73 | ||
| Volume | 1,358,722 | ||||
| More AMLN Info: Chart SEC Filings Profile Historical Options | |||||
Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first- in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) ...more
Daniel M. Bradbury - CEO
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| LLY | 22 | ALKS | 14 |
| YHOO | 10 | BIIB | 9 |
| GILD | 8 | C | 5 |
| NVO | 5 | WFC | 5 |
| TIN | 4 | BIIB | 4 |
| GE | 4 | RFMD | 4 |
on Sep 24, 2009
at 05:17 AM messy Amylin stock hasnt been able to bounce much off the lows, there is reason to be suspicious.
Article: Hapoalim Securities Initiates Coverage on Amylin Pharmaceuticals (AMLN) with a Sell; Lose-Lose Scenario
on Sep 23, 2009
at 06:01 PM Short selling manipulation One would wonder about the timing and "insight" associated with this non-news "initiates coverage" announcement. The SEC should get off its sorry behind and police this kind of manipulative nonsense.
Article: Hapoalim Securities Initiates Coverage on Amylin Pharmaceuticals (AMLN) with a Sell; Lose-Lose Scenario
on Sep 23, 2009
at 11:56 AM Makes me wonder ... The "analysis" offered is extermely stale since EXACTLY the same thing could have been said many to several months ago. Why has "Hapoalim" suddenly struggled to consciousness? Hmmm? These sorts of "analyses" are typical of those that collude in short games. Have fun.
Article: Hapoalim Securities Initiates Coverage on Amylin Pharmaceuticals (AMLN) with a Sell; Lose-Lose Scenario
on Jul 23, 2009
at 03:37 PM Victoza vs Byetta I was moved on to Byetta from insulin in 2008 for a period of 9 months. Everything was fine for 7 months and I lost 42 pounds in weight and my glucoze control was excellent. Unfortunately, after 7 months my glucoze levels increased dramatically and my weight started to increase once again and after taking Byetta for 9 months I had to go back to insulin once again and my weight has increased to a higher level than it was when I started Byetta.although my glucoze levels have once again come under control. I have today been introduced to Victoza by my diabetic consultant and I hope to be accepted to receive this new product. I believe that the more people that are able to try these new items the better and more accurate studies will become. Who knows, with us being fortunate enough to try these new products one day there will be total control for all!
Article: Novo Nordisk's (NVO) Victoza Returns More Promising Results Than Lilly's (LLY)/Amylin's (AMLN) Byetta
on Jul 8, 2009
at 06:21 PM Victoza Vs Byetta one study, doesnt mean anything. I have been on Byetta for 3 years, my glucose control is excellent
Article: Novo Nordisk's (NVO) Victoza Returns More Promising Results Than Lilly's (LLY)/Amylin's (AMLN) Byetta